MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1

Bone Research

Volumn 3, Issue , 2015, Pages

  Tan, Xinyu ^a   Fan, Shicai ^a   Wu, Wen ^a   Zhang, Yin ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA 26A; SOMATOMEDIN C;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; EMBRYO; GENE OVEREXPRESSION; GENE TARGETING; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MOUSE; NONHUMAN; OSTEOSARCOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; U2OS CELL LINE;

EID: 84979263829     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2015.33     Document Type: Article

References (28)

1. He JP, Hao Y, Wang XL et al. Review of the molecular pathogenesis of osteosarcoma. Asian Pac J Cancer Prev 2014; 15: 5967-5976.
2. Haddox CL,Han G, Anijar L et al. Osteosarcoma in pediatric patients and young adults: a single institution retrospective review of presentation, therapy, and outcome. Sarcoma 2014; 2014: 402509.
3. He H, Ni J, Huang J. Molecular mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett 2014; 7: 1352-1362.
4. Zhang Y, Yang Q,Wang S. MicroRNAs: a new key in lung cancer. Cancer Chemother Pharmacol 2014; 74: 1105-1111.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
6. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
7. Sharma G, Dua P, Agarwal SM. A comprehensive review of dysregulated miRNAs involved in cervical cancer. Curr Genomics 2014; 15: 310-323.
8. Li XJ, Ren ZJ, Tang JH. MicroRNA-34a: a potential therapeutic target in human cancer. Cell Death Dis 2014; 5: e1327.
9. Deng M, Liu JF, Gu YX, Zheng GP, He ZM. [miR-216b suppresses cell proliferation and invasion by targeting PKC alpha in nasopharyngeal carcinoma cells.] Zhonghua Zhong Liu Za Zhi 2013; 35: 645-650. [Article in Chinese]
10. Deng M, Ye Q, Qin Z et al. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. Tumour Biol 2013; 34: 1793-1800.
11. Gao J, Li L, Wu M et al. MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1. PLoS One 2013; 8: e65138.
12. Deng M, Tang HL, Lu XH et al. MiR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer. PLoS One 2013; 8: e72662.
13. Kota J, Chivukula RR, O'Donnell KA et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-1017.
14. Yang X, Liang L, Zhang XF et al. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology 2013; 58: 158-170.
15. Zhang J, Han C, Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin. Gastroenterology 2012; 143: 246-256, e8.
16. Song QC, Shi ZB, Zhang YT et al. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients. Oncol Rep 2014; 31: 1263-1270.
17. Zhao H, LiM, Li L, Yang X, Lan G, Zhang Y. MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis. PLoS One 2013; 8: e83571.
18. Jin J, Cai L, Liu ZM, Zhou XS. miRNA-218 inhibits osteosarcoma cell migration and invasion by down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev 2013; 14: 3681-3684.
19. Huang J, Gao K, Lin J,Wang Q. MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61. Tumour Biol 2014; 35: 1095-1100.
20. Yang X, Zhang XF, Lu X et al. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factorcMet pathway. Hepatology 2014; 59: 1874-1885.
21. Huse JT, Brennan C, Hambardzumyan D et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23: 1327-1337.
22. Alajez NM, Shi W, Hui AB et al. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death Dis 2010; 1: e85.
23. Lu J, He ML,Wang L et al. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 2011; 71: 225-233.
24. Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. J Bone Miner Res 2008; 23: 287-295.
25. Zhu Y, Lu Y, Zhang Q et al. MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein. Nucleic Acids Res 2012; 40: 4615-4625.
26. Li ZJ, Ying XJ, Chen HL et al. Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer. World J Gastroenterol 2013; 19: 7788-7794.
27. Djiogue S, Nwabo Kamdje AH, Vecchio L et al. Insulin resistance and cancer: the role of insulin and IGFs. Endocr Relat cancer 2013; 20: R1-R17.
28. Arnaldez FI, Helman LJ. Targeting the insulin growth factor receptor 1. Hematol Oncol Clin North Am 2012; 26: 527-542, vii-viii.